Adam Halberstadt dating history

Details

Adam L. Halberstadt is an American neuroscientist and pharmacologist who studies psychedelic drugs from a cross-species translational perspective. He is a Professor at the University of California, San Diego (UCSD) and the Director of the UCSD Center for Psychedelic Research. One of his most notable contributions has been the development of an automated assay for the head-twitch response, a behavioral proxy of psychedelic effects in animals. He has used the head-twitch response assay to investigate the 5-HT2A receptor signaling mechanisms involved in the effects of psychedelic drugs. He is one of the Principal Investigators on a clinical trial being conducted at UCSD to test whether psilocybin can relieve phantom limb pain in amputees. In February 2021, he formed a collaboration with COMPASS Pathways to develop novel psychedelic drugs as therapeutics. In 2022, has was listed as an inventor on an application for a US Patent covering novel 5-HT2A ligands acting as partial or biased agonists. He has also collaborated with BetterLife Pharma Inc. on a project designed to investigate the pharmacology of the non-psychedelic LSD derivative BOL-148, also known as 2-bromo-LSD. Halberstadt received his bachelor's degree in neuroscience from the University of Delaware in 1998 and his Doctor of Philosophy in neurobiology from the University of Pittsburgh in 2006.